- Home
- FTDR vs PRCT Comparison
FTDR vs PRCT Comparison
Compare FTDR & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTDR
- PRCT
- Stock Information
- Founded
- FTDR 1971
- PRCT 2009
- Country
- FTDR United States
- PRCT United States
- Employees
- FTDR N/A
- PRCT N/A
- Industry
- FTDR Diversified Commercial Services
- PRCT Medical Specialities
- Sector
- FTDR Finance
- PRCT Health Care
- Exchange
- FTDR Nasdaq
- PRCT Nasdaq
- Market Cap
- FTDR 2.8B
- PRCT 2.9B
- IPO Year
- FTDR 2018
- PRCT 2021
- Fundamental
- Price
- FTDR $39.64
- PRCT $53.03
- Analyst Decision
- FTDR Hold
- PRCT Strong Buy
- Analyst Count
- FTDR 5
- PRCT 7
- Target Price
- FTDR $50.25
- PRCT $91.43
- AVG Volume (30 Days)
- FTDR 1.0M
- PRCT 1.0M
- Earning Date
- FTDR 05-01-2025
- PRCT 04-24-2025
- Dividend Yield
- FTDR N/A
- PRCT N/A
- EPS Growth
- FTDR 41.98
- PRCT N/A
- EPS
- FTDR 3.01
- PRCT N/A
- Revenue
- FTDR $1,843,000,000.00
- PRCT $224,498,000.00
- Revenue This Year
- FTDR $11.94
- PRCT $46.28
- Revenue Next Year
- FTDR $6.50
- PRCT $32.67
- P/E Ratio
- FTDR $13.17
- PRCT N/A
- Revenue Growth
- FTDR 3.54
- PRCT 64.84
- 52 Week Low
- FTDR $29.41
- PRCT $47.04
- 52 Week High
- FTDR $63.49
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- FTDR 46.40
- PRCT 42.69
- Support Level
- FTDR $37.83
- PRCT $51.27
- Resistance Level
- FTDR $40.86
- PRCT $54.75
- Average True Range (ATR)
- FTDR 2.05
- PRCT 3.64
- MACD
- FTDR 0.63
- PRCT 0.19
- Stochastic Oscillator
- FTDR 76.76
- PRCT 49.48
About FTDR Frontdoor Inc.
Frontdoor Inc is a United States-based company that provides home service plans. It owns multiple home service brands including American Home Shield, HSA, OneGuard, and Landmark brands. Through its home service plans, the company helps its customers maintain their homes and protect against costly and unexpected breakdowns of essential home systems and appliances.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.